31st Tashkent International Healthcare Exhibition – TIHE 2027

20 - 22 April 2027, Uzexpocentre NEC / Tashkent, Uzbekistan

News

In Uzbekistan, the criteria for selling medicines without a prescription have been changed

At the same time, the safety of self-administration of the drug and the risks of its improper use, overdose, abuse, and dependence will be assessed.

In Uzbekistan, the procedure for classifying medicines as prescription and over-the-counter categories has been revised. This was reported by the Ministry of Justice.

The relevant document was registered on November 12, 2026. It has improved the criteria by which drugs may be classified as over-the-counter.

Now, when making such a decision, it will be taken into account whether the drug can be safely used independently, without constant supervision by a medical worker, as well as how low the risk of improper use, overdose, abuse, or dependence is.

In addition, the clarity of the instructions for the consumer, the results of drug safety monitoring, and the classification adopted by regulatory authorities recognized by the World Health Organization will be assessed.

According to the new rules, drugs containing two or more active substances may also be classified as over-the-counter. At the same time, the therapeutic significance of each component, the benefit-risk ratio of the combination, its clinical justification, and the likelihood of improper use will be assessed.

The applicant will also be able to reapply with a request to reclassify a drug from prescription to over-the-counter without waiting for three years to pass. This is possible if the reasons for the previous refusal have been eliminated or new data on the safety and efficacy of the medicine have emerged.

The authorized body, in turn, will be able to review the drug category on the basis of new scientific data, the results of safety monitoring, or changes in legislation.

Source
PARTNERS